The Spending Plan policy 23: stop prescribing branded medicines where cheaper generics are suitable

May 14, 2015 10:20 AM

Each day we are publishing a blog on one of the policies from our Spending Plan.
Click here to read them all.

Doctors and prescribing nurses too often write prescriptions for drugs that are cheap and available to buy off the shelf in pharmacists and supermarkets, such as paracetamol. However, there is a significant cost to taxpayers every time that a prescription is written and administered. Given that the majority of prescriptions written are free for the user – but paid for by taxpayers – there is very little concern about the cost of providing drugs like paracetamol via traditional prescriptions. What can make this process even more expensive is when patients are prescribed branded medicines when there are cheaper generic alternatives available, which are just as effective. In evidence to the Commons Health Committee, the British Generic Manufacturers Association estimated it to be £140 million.

Branded and Non-Branded medicine prescriptions NHS

It is worth noting that the opposite can also sometimes be true – generic drugs can sometimes be more expensive than branded alternatives. Much more has to be done to provide the most effective drug, both in how it will help the patient and how it will cut costs. The NHS should implement systems to ensure that prescribers have to actively choose a more expensive alternative and that the practice, not the NHS, pays the premium when there is no medical reason for it.


We have written elsewhere about further savings that could be made with smarter prescribing such as in the case of Avastin and Lucentis.

Latest Blogs:

But that wasn't real socialism...

4:04 PM 23, May 2018 Matt Gillow

Food would be cheaper outside the customs union

4:20 PM 14, May 2018 James Price

Time to scrap inheritance tax

3:34 PM 08, May 2018 Matt Gillow

Why we publish the Town Hall Rich List

2:44 PM 11, Apr 2018 Jan Zeber

The New Bucks Unitary Authority

11:23 AM 15, Mar 2018 Jan Zeber